Evidence map›Paper›PMID 32920245›Full record

ArticlePsychiatry research. Neuroimaging2020

Orbitofrontal sulcogyral morphology in patients with cocaine use disorder.

Marisa A Patti, Sarah Wochele, Yirui Hu, Paul S Regier, Anna Rose Childress, Vanessa Troiani

Open access · greenAbstract read
In one paragraph

Article in Psychiatry research. Neuroimaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Marisa A PattiGeisinger-Bucknell Autism & Developmental Medicine Institute, Geisinger, 120 Hamm Drive, Suite 2A, Lewisburg, PA 17837, United States. Electronic address: marisa_patti@brown.edu.
Sarah WocheleGeisinger-Bucknell Autism & Developmental Medicine Institute, Geisinger, 120 Hamm Drive, Suite 2A, Lewisburg, PA 17837, United States.
Yirui HuDepartment of Population Health Sciences, Geisinger, Danville, PA, United States.
Paul S RegierCenter for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Anna Rose ChildressCenter for Studies of Addiction, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
Vanessa TroianiGeisinger-Bucknell Autism & Developmental Medicine Institute, Geisinger, 120 Hamm Drive, Suite 2A, Lewisburg, PA 17837, United States; Department of Imaging Science and Innovation, Center for Health Research, Geisinger, Danville, Pennsylvania, United States; Neuroscience Institute, Geisinger, Danville, Pennsylvania, United States; Department of Basic Sciences, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States. Electronic address: vtroiani@geisinger.edu.
Autism & Developmental Medicine Institute · USUniversity of Pennsylvania · USGeisinger Health System · USGeisinger Medical Center · US

Funding

Two Medications to Treat Cocaine and Alcohol DependenceP50DA012756 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI KAMPMAN, KYLE MATTHEW · 1999 to 2013
$17.4M
Center for the Development of Novel Medications for Cocaine DependenceU54DA039002 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI KAMPMAN, KYLE MATTHEW · 2014 to 2018
$5.1M
T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
Supplemental Application for Clinical and Genetic Risk Profile of Opioid Use DisorderR01DA044015 · NIDA · GEISINGER CLINIC · PI BERRETTINI, WADE H, ROBISHAW, JANET D · 2017 to 2021
$4.5M
Targeting dopamine D3 receptors in cocaine addictionR01DA039215 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHILDRESS, ANNA ROSE · 2016 to 2019
$2.5M
BRAIN BLOOD FLOW IMAGING OF COCAINE WITHDRAWAL &CRAVINGR01DA010241 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHILDRESS, ANNA ROSE · 1996 to 2004
$1.9M
Extinction of Limbic Activation to "Unseen" Cocaine CuesR01DA025906 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHILDRESS, ANNA ROSE · 2009 to 2010
$1.2M
1 of 2: Real-time fMRI Pattern Training for Treatment of Craving and AddictionR33DA026114 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHILDRESS, ANNA ROSE · 2010 to 2011
$1.2M
1 of 2: Real-time fMRI Pattern Training for Treatment of Craving and AddictionR21DA026114 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CHILDRESS, ANNA ROSE · 2008 to 2009
$883k
NIDA NIH HHS P50 DA012756NIDA NIH HHS R01 DA010241NIDA NIH HHS R01 DA025906NIDA NIH HHS R01 DA039215NIDA NIH HHS R01 DA044015NIDA NIH HHS R21 DA026114NIDA NIH HHS R33 DA026114NIDA NIH HHS T32 DA028874NIDA NIH HHS U54 DA039002
6 · The paper itself

Abstract

Orbitofrontal cortex (OFC) is thought to be involved in appropriate processing of rewarding stimuli, and abnormal OFC structure and function has been found in patients with substance use disorders. Atypical patterns of the H-sulcus in the OFC have been primarily identified with schizophrenia, but also with bipolar disorder, both of which are associated with comorbid substance use. Given the high rates of substance use within Axis I psychiatric disorders, it is reasonable to consider how frequencies of OFC patterns in populations with only substance use compare to controls. This information is crucial to disentangle whether atypical frequencies of H-sulcus sulcogyral patterns within psychopathology are associated with the psychiatric or substance use phenotype. Here, we present the first analysis of H-sulcus sulcogyral patterns in a population of adult black men with (n = 84) and without (n = 24) cocaine use disorder (CUD). We find that OFC sulcogyral patterns are not significantly different from the control group, indicating that OFC sulcogyral patterns are not disrupted in patients with CUD. As exploratory analyses, we describe OFC sulcogyral pattern subtypes in this cohort as well as an additional control group (n = 52), in order to add to the growing body of literature on OFC sulcogyral pattern characterization.

Indexed as

CocaineSchizophreniaSubstance-Related DisordersHumansMagnetic Resonance ImagingMalePrefrontal CortexCocaineGyrificationOFCSulcusVentromedial prefrontal cortex

Identifiers

PMID32920245
PMCPMC8126989
OpenAlexW3082987588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.